Featured News
Traverse Biosciences Executes Exclusive, Worldwide License Agreement
Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreMillennial Materials and Devices Presenting at NY Business Plan Competition FinalsApr 8 2015
Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreNew Mathematical Model May Improve Drug Discovery - Study Co-Authored by CFB's Dr. Eleanor AllenApr 22 2015
A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn More-
Long Island Bioscience Hub Appoints Additional BioEntrepreneurs-In-ResidenceAugust 22, 2018
Seasoned Industry Veterans Join Long Island Bioscience Hub’s BioEntrepreneur-in-Residence Initiative
Learn More -
Client News: First In-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to be LaunchedAugust 13, 2018
CFB Client iCell Gene Therapeutics, Stony Brook University, and the University of Louisville, have received FDA clearance for an Investigational New Drug (IND) for the treatment of relapsed and refractory T-cell leukemia and lymphoma.
Learn More -
Funding Opportunity: Gund-Harrington Scholar Award for Fighting Blindness
The Gund-Harrington Initiative for Fighting Blindness announces the call for proposals for the 2019 Gund-Harrington Scholar Award. The Gund-Harrington Scholar Award supports innovative research efforts that could prevent, treat or cure blindness resulting from inherited retinal degenerative diseases. The Gund-Harrington …
Learn More
Upcoming Events
No Events